Our Real-Life Market-Beating U.S. Stock Portfolio, Ten Years After
Discover the successful decade-long journey of a stock portfolio focusing on dividend growth companies, outperforming the S&P ...
‘He’s a coward investor’: Grant Cardone says Warren Buffett’s big investments have 1 crucial trait in common — it makes money ‘while you sleep’ so you don’t ...
While Cardone's words come off as an insult, the real estate mogul happily uses the term "coward investor" to describe ...
Mitsubishi UFJ Financial Showed Us The Money, And We Upgrade This Bank
Mitsubishi UFJ Financial Group's dividend yield and buyback program boost value. Learn why MUFG stock is a solid investment ...
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Warren Buffett Has Two-Thirds of Berkshire Hathaway's $297 Billion Portfolio Invested in 5 Magnificent Stocks
Buffett strongly believes in concentrating Berkshire Hathaway's investment capital into his best ideas. Five top-tier ...
'It's not taxed at all': Warren Buffett shared the 'best investment' you can make to fight inflation — how to put his advice into action
With an estimated net worth of $117 billion, Warren Buffett, the CEO of Berkshire Hathaway, has built a tremendous financial ...
DHT, Evolve Technologies, and More Stocks See Action From Activist Investors
D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of ...
Trump Tariff News, Economic Data Create Uncertainty. How This Trader Says You Should React.
Trump tariff news, earnings and economics are creating market uncertainty. Jeffrey Hirsch explains how traders should react.
Titan Pharmaceuticals (NASDAQ:TTNP) Coverage Initiated by Analysts at StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on ...